Articles

Our eventual goal is to allow for the use of this tool by clinicians, especially for the care of patients with advanced-stage disease for whom the immediate FDA-approved therapy choices have been exhausted

Our eventual goal is to allow for the use of this tool by clinicians, especially for the care of patients with advanced-stage disease for whom the immediate FDA-approved therapy choices have been exhausted. APPENDIX TABLE A1. Curated FDA-Targeted Cancer Therapies Read more…